Bob Löwenberg
Oprichter bij Frame Pharmaceuticals BV
Profiel
Bob Löwenberg is the founder of SkylineDx BV, established in 2005, and Frame Pharmaceuticals BV, established in 2018, where he holds the title of Chief Marketing Officer.
Dr. Löwenberg's current jobs include being a Professor at Erasmus University Rotterdam and a Member of The Royal Netherlands Academy of Arts & Sciences.
Dr. Löwenberg's former job was as the Chief Scientific Officer at Skyline Diagnostics BV from 2005 to 2013.
Dr. Löwenberg holds a doctorate from Erasmus University Rotterdam and a graduate degree from the University of Groningen.
Dr. Löwenberg is also the founder of Introgene BV.
Actieve functies van Bob Löwenberg
| Bedrijven | Functie | Begin |
|---|---|---|
| Erasmus University Rotterdam | Corporate Officer/Principal | - |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Corporate Officer/Principal | - |
Frame Pharmaceuticals BV
 Frame Pharmaceuticals BV BiotechnologyHealth Technology Part of CureVac NV, Frame Pharmaceuticals BV is a Dutch company that offers cancer therapy services. The company is based in Amsterdam, Netherlands. The company was founded by Ronald Plasterk, Bob Löwenberg. Ronald Plasterk has been the CEO since incorporation. Frame Pharmaceuticals was acquired by CureVac NV on June 08, 2022 for $34.26 million. | Oprichter | 27-12-2018 |
Eerdere bekende functies van Bob Löwenberg
| Bedrijven | Functie | Einde |
|---|---|---|
Skyline Diagnostics BV
 Skyline Diagnostics BV Electronic Equipment/InstrumentsElectronic Technology Skyline Diagnostics develops and commercializes diagnostic microarrays for oncology. These tests currently provide the healthcare professional diagnostic information using one comprehensive test and may be useful in the clinical management of patients with cancer. Skyline Diagnostics products are currently available research only tools in the United States. The development pipeline includes diagnostic tests for Acute Myeloid Leukemia, Multiple Myeloma, Acute Lymphatic Leukemia, and Brain tumors. | Hoofd Techniek/Wetenschap/O&O | 22-08-2013 |
| Introgene BV | Corporate Officer/Principal | 23-10-2008 |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Oprichter | - |
Opleiding van Bob Löwenberg
| University of Groningen | Graduate Degree |
| Erasmus University Rotterdam | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Skyline Diagnostics BV
Skyline Diagnostics BV Electronic Equipment/InstrumentsElectronic Technology Skyline Diagnostics develops and commercializes diagnostic microarrays for oncology. These tests currently provide the healthcare professional diagnostic information using one comprehensive test and may be useful in the clinical management of patients with cancer. Skyline Diagnostics products are currently available research only tools in the United States. The development pipeline includes diagnostic tests for Acute Myeloid Leukemia, Multiple Myeloma, Acute Lymphatic Leukemia, and Brain tumors. | Electronic Technology |
The Royal Netherlands Academy of Arts & Sciences
The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Commercial Services |
| Introgene BV | Health Technology |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Health Services |
Frame Pharmaceuticals BV
Frame Pharmaceuticals BV BiotechnologyHealth Technology Part of CureVac NV, Frame Pharmaceuticals BV is a Dutch company that offers cancer therapy services. The company is based in Amsterdam, Netherlands. The company was founded by Ronald Plasterk, Bob Löwenberg. Ronald Plasterk has been the CEO since incorporation. Frame Pharmaceuticals was acquired by CureVac NV on June 08, 2022 for $34.26 million. | Health Technology |
